Skip to main content

Selenium in Ischemic Stroke

  • Chapter
  • First Online:
Selenium

Abstract

Selenium plays a significant role in brain physiology, whereas data on the role of selenium in stroke pathophysiology are inconsistent. The objective of this chapter is to review current findings on the role of selenium in ischemic stroke. The existing human data demonstrate that stroke is associated with significantly reduced Se levels as well as glutathione peroxidase activity. Oppositely, we have revealed significantly higher serum Se levels in stroke, being inversely associated with brain damage markers. However, Se supplementation trials in stroke patients provided inconsistent results. Experimental studies provided a significant contribution to potential neuroprotective effects in stroke. Se supplementation was shown to increase antioxidant enzyme activity, thus reducing reactive oxygen species (ROS) production and macromolecule oxidative damage. Se-induced prevention of mitochondrial dysfunction may also significantly contribute to reduced ROS production and restoration of ATP levels. Se exposure was also shown to prevent NF-kB and AP-1 activation, thus reducing proinflammatory cytokine production and leukocyte infiltration. Reduce caspase 3 activation and apoptosis, as well as decreased autophagy, were observed under ischemic conditions in Se-treated animals. Se may also reduce adhesion molecule expression, as well as glutamate excitotoxicity, although these effects were not demonstrated in stroke models. The existing data demonstrate the neuroprotective potential of selenium in ischemic stroke. However, the majority of indications of the neuroprotective effect of selenium arise from experimental studies, whereas human data remain insufficient. Further clinical studies and especially placebo-controlled trials are strongly required to highlight the potential effects of selenium supplements in ischemic stroke management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

Download references

Acknowledgments

The publication was prepared with the support of the RUDN University Program 5-100.

Conflict of Interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anatoly V. Skalny .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Skalny, A.V., Skalnaya, M.G., Klimenko, L.L., Mazilina, A.N., Tinkov, A.A. (2018). Selenium in Ischemic Stroke. In: Michalke, B. (eds) Selenium. Molecular and Integrative Toxicology. Springer, Cham. https://doi.org/10.1007/978-3-319-95390-8_11

Download citation

Publish with us

Policies and ethics